Prof. Dr. med. Frank Berthold
When a child is diagnosed with cancer, this is a huge burden for the entire family. Nothing is ever the same again. At University Hospital Cologne, we support the entire family during treatment.
Children and young people up to the age of 18 suffer from different types of cancer than adults. The most common types are cancer of the hematopoietic system – leukaemia and lymphoma. Brain tumours and neuroblastoma, as well as bone, renal and soft tissue tumours are also more common in children than in adults.
Modern diagnostics and forms of therapy
Thanks to state-of-the-art medical possibilities, three out of four patients under the age of 18 can be cured in the long term. At University Hospital Cologne, we can offer the entire range of modern diagnostics and therapy for children with blood disease or tumours, including bone marrow transplants.
Which therapy is best suited varies from one patient to the next. At University Hospital Cologne, experienced specialists from different areas of medicine work hand in hand to find the right treatment plan for each individual patient. In doing so, they rely on recommendations by the German Society for Paediatric Oncology and Haematology and other national and international institutes.
University Hospital Cologne is conducting a vast range of trials
In children's oncology, research at University Hospital Cologne is focused on neuroblastoma. The study group headed by Professor Frank Berthold has prepared many publications on this subject, some of which have received international recognition. In order to gain a better understanding of how the disease emerges and to develop new approaches for therapy, scientists at University Hospital Cologne are examining the molecular basis of neuroblastoma. We are also involved in a number trials by the German Society for Paediatric Oncology and Haematology and other national and international institutes.
Our patients benefit from research activities at University Hospital Cologne which frequently provide them with fast access to new methods of therapy.